Prostar Adverse Events: FDA MAUDE Data
ABBOTT VASCULAR INC. · Vascular Hemostasis/Closure Device · First cleared May 2019
Total Reports
375
Reports (30d)
0
Active Signals
0
Open Recalls
0
Evidence
Related research
<scp>Real‐world</scp> experience of <scp>suture‐based</scp> closure devices: Insights from the <scp>FDA</scp> Manufacturer and User Facility Device Experience
Brian C. Case, et al. · Catheterization and Cardiovascular Interventions · 2021
The Safety and Effectiveness of the Prostar XL Closure Device Compared to Open Groin Cutdown for Endovascular Aneurysm Repair
Tilda Hahl, et al. · Vascular and Endovascular Surgery · 2023
Vascular Closure Devices for Large Bore Femoral Access After Transfemoral Transcatheter Aortic Valve Replacement: A Network Meta‐Analysis
Sunil Upadhaya, et al. · Catheterization and Cardiovascular Interventions · 2025
Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry
Sérgio Berti, et al. · Journal of the American Heart Association · 2020
Vascular Complications Among Patients Undergoing Trans-femoral Transcatheter Aortic Valve Implantation: Prostar <i>vs</i> ProGlide Parallel Technique
Erez Marcusohn, et al. · Angiology · 2022
Citations indexed from PubMed.
Keep exploring
Related devices in Coronary
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,635 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,655 reports
PERCLOSE
ABBOTT VASCULAR INC. · 10,082 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,727 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 6,095 reports
Resolute Onyx
MEDTRONIC, INC. · 4,494 reports
Want automated safety signal detection?
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.
Get Early AccessUnderstanding this data